Clinical Trial Update: Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

View source ↗

Summary

This clinical trial update examines how raltegravir affects the HIV-1 cDNA slope after initiation of antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Christoph Stephan | Conditions: HIV-1 | Status: COMPLETED